Price Alert

Lyra Therapeutics Inc. (LYRA)

NASDAQ: LYRA · Real-Time Price · USD

7.06

-0.04 (-0.56%)

At close: Aug 15, 2025, 3:59 PM

6.87

-2.69%

After-hours: Aug 15, 2025, 06:51 PM EDT

Lyra Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021
Period Ending	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021
Cash & Equivalents	29.78M	31.73M	40.58M	23.8M	31.91M	15.8M	22.35M	24.85M	54.36M	22.02M	32.55M	109.56M	120.67M	33.76M	45.75M	58.13M	69.05M	66.11M
Short-Term Investments	n/a	n/a	n/a	27.83M	35.59M	71.32M	80.4M	77.7M	61.79M	60.69M	65.34M	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Long-Term Investments	n/a	1.99M	1.99M	n/a	1.99M	1.99M	1.39M	n/a	1.09M	n/a	1.39M	n/a	1.09M	329K	329K	329K	329K	329K
Other Long-Term Assets	1.99M	n/a	n/a	1.99M	n/a	683K	1.11M	8.86M	4.35M	5.24M	3.28M	2.87M	1.7M	1.08M	762K	245K	243K	n/a
Receivables	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	5M	n/a	n/a	n/a	n/a
Inventory	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	1.28M	2.17M	2.45M	2.82M	1.94M	2.33M	2.07M	2.37M	2.1M	2.09M	2.94M	329K	329K	n/a	2.17M	2.75M	1.03M	n/a
Total Current Assets	31.06M	33.91M	43.02M	54.44M	69.44M	89.44M	104.82M	104.92M	118.25M	84.8M	100.83M	112.23M	122.38M	40.55M	47.92M	60.89M	70.07M	67.35M
Property-Plant & Equipment	19.52M	20.42M	21.33M	22.32M	23.16M	49.41M	35.28M	6.8M	1.98M	3.83M	4.47M	4.36M	4.87M	5.38M	5.86M	6.3M	5.69M	5.24M
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	21.51M	22.41M	23.32M	24.31M	25.15M	52.08M	37.78M	15.65M	7.42M	9.07M	9.14M	7.23M	7.65M	6.79M	6.95M	6.88M	6.26M	5.57M
Total Assets	52.57M	56.32M	66.35M	78.76M	94.58M	141.53M	142.6M	120.58M	125.67M	93.87M	109.97M	119.46M	130.03M	47.34M	54.87M	67.76M	76.33M	72.92M
Account Payables	680K	725K	1.18M	2.29M	4.97M	2.84M	3.13M	5.05M	4.19M	3.95M	2.62M	2.9M	1.67M	2.41M	3.13M	2.91M	1.9M	1.17M
Deferred Revenue	32K	216K	398K	607K	814K	1.32M	1.66M	1.73M	1.5M	1.51M	1.27M	2.73M	1.81M	10.06M	9.79M	9.84M	12M	1.93M
Short-Term Debt	4.55M	n/a	n/a	n/a	n/a	4.5M	5.43M	1.4M	1.69M	n/a	1.96M	654K	926K	1.1M	n/a	1.05M	n/a	n/a
Other Current Liabilities	6.58M	4.04M	4.82M	4.86M	3.13M	-4.5M	-730K	-1.4M	-1.69M	n/a	6.05M	3.58M	2.45M	1.61M	1.83M	672K	1.17M	781K
Total Current Liabilities	11.16M	11.47M	12.63M	14.95M	19.28M	18.72M	19.6M	19.23M	14.11M	14.15M	14.47M	13.61M	9.87M	17.8M	18.25M	17.77M	5.9M	4.17M
Long-Term Debt	27.93M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	11.86M	n/a	n/a	n/a	n/a	11.94M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Liabilities	39.79M	40.97M	42.12M	43.18M	44.33M	45.3M	33.58M	17.1M	12.99M	13.62M	14.74M	12.64M	9.13M	1.39M	2.31M	2.8M	12.93M	1.2M
Total Liabilities	50.95M	52.44M	54.75M	58.14M	63.6M	64.02M	53.18M	36.34M	27.1M	27.78M	29.21M	26.24M	19M	19.19M	20.55M	20.57M	18.83M	5.37M
Total Debt	32.48M	33.36M	34.38M	35.32M	36.75M	37.86M	26.88M	6.29M	1.69M	2.09M	2.22M	657K	929K	1.2M	1.45M	1.71M	1.96M	2.2M
Common Stock	2K	66K	65K	65K	65K	61K	57K	50K	50K	32K	32K	32K	32K	13K	13K	13K	13K	13K
Retained Earnings	-420.77M	-413.34M	-404.79M	-393.81M	-381.94M	-333.81M	-311.36M	-296.2M	-280.55M	-264.93M	-248.68M	-234.44M	-214.89M	-200.41M	-193.4M	-179.78M	-168.72M	-157.69M
Comprehensive Income	n/a	n/a	n/a	20K	-4K	25K	33K	-7K	-27K	-12K	10K	n/a	-0.00	n/a	n/a	n/a	-0.00	0.00
Shareholders Equity	1.62M	3.87M	11.59M	20.62M	30.98M	77.5M	89.42M	84.24M	98.58M	66.09M	80.75M	93.22M	111.03M	28.16M	34.32M	47.19M	57.5M	67.55M
Total Investments	n/a	1.99M	1.99M	27.83M	35.59M	73.31M	81.79M	77.7M	61.79M	60.69M	65.34M	n/a	1.09M	329K	329K	329K	329K	329K